• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结核分枝杆菌与肺部合并感染:系统评价

Non-Tuberculous Mycobacteria and Lung Co-Infection: Systematic Review.

作者信息

Fayos Marina, Silva Jose Tiago, López-Medrano Francisco, Aguado José María

机构信息

Unit of Infectious Diseases, Department of Internal Medicine, University Hospital 12 de Octubre, 28041 Madrid, Spain.

Instituto de Investigación Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain.

出版信息

J Clin Med. 2022 Sep 23;11(19):5619. doi: 10.3390/jcm11195619.

DOI:10.3390/jcm11195619
PMID:36233487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9571699/
Abstract

Non-tuberculous mycobacteria (NTM) and pulmonary co-infection occurs in patients with underlying lung disease and is rarely reported. We conducted a systematic search of NTM and pulmonary co-infection in PubMed, EMBASE, and Cochrane Library to identify cases published from 1977 to May 2022. We included 507 articles comprising 1538 cases (only 817 patients with partial relevant clinical data). Of these, 54.3% of patients were men, with a mean age of 57.7 years. Chronic obstructive pulmonary disease (21.1%), previous diagnosis of tuberculosis (18%), and asthma (11.1%) were the most common chronic lung diseases, and corticosteroids were used in 36.8% of patients. The most frequent symptoms were cough (68.2%), dyspnea (59.1%), and hemoptysis (34.1%). The most common radiological findings were bronchiectasis (52.3%) and cavitation (40.8%). NTM and were treated simultaneously in 47.3% of cases, whereas NTM-targeted therapy only was performed in 23.4% and only in 1.6%. The remaining 27.7% did not receive any treatment and were considered to be colonized. The global mortality rate was 43% (159/370). There was an increased prevalence of NTM and pulmonary aspergillosis among patients with underlying chronic lung diseases, which led to severe pulmonary affection with a poor global prognosis.

摘要

非结核分枝杆菌(NTM)与肺部合并感染发生于有基础肺部疾病的患者中,且鲜有报道。我们在PubMed、EMBASE和Cochrane图书馆系统检索了NTM与肺部合并感染的相关文献,以识别1977年至2022年5月发表的病例。我们纳入了507篇文章,共1538例病例(仅有817例患者有部分相关临床数据)。其中,54.3%的患者为男性,平均年龄为57.7岁。慢性阻塞性肺疾病(21.1%)、既往有结核病诊断史(18%)和哮喘(11.1%)是最常见的慢性肺部疾病,36.8%的患者使用了皮质类固醇。最常见的症状为咳嗽(68.2%)、呼吸困难(59.1%)和咯血(34.1%)。最常见的影像学表现为支气管扩张(52.3%)和空洞形成(40.8%)。47.3%的病例同时对NTM和 进行了治疗,而仅针对NTM进行治疗的占23.4%,仅针对 进行治疗的占1.6%。其余27.7%未接受任何治疗,被认为是定植状态。全球死亡率为43%(159/370)。在有基础慢性肺部疾病的患者中,NTM与肺曲霉病的患病率增加,这导致严重的肺部病变,全球预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8512/9571699/c79aa0b9e5c2/jcm-11-05619-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8512/9571699/c79aa0b9e5c2/jcm-11-05619-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8512/9571699/c79aa0b9e5c2/jcm-11-05619-g001.jpg

相似文献

1
Non-Tuberculous Mycobacteria and Lung Co-Infection: Systematic Review.非结核分枝杆菌与肺部合并感染:系统评价
J Clin Med. 2022 Sep 23;11(19):5619. doi: 10.3390/jcm11195619.
2
A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity.一项与无免疫功能改变的成人非结核分枝杆菌肺病治疗决策相关因素的回顾性研究。
BMC Infect Dis. 2018 Dec 14;18(1):659. doi: 10.1186/s12879-018-3559-x.
3
[Analysis of chronic necrotizing pulmonary aspergillosis (CNPA) cases complicated with non-tuberculous mycobacteriosis (NTM)].[慢性坏死性肺曲霉病(CNPA)合并非结核分枝杆菌病(NTM)病例分析]
Kekkaku. 2008 Aug;83(8):573-5.
4
Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis.支气管扩张症中的非结核分枝杆菌病和曲霉相关肺部疾病。
Eur Respir J. 2006 Aug;28(2):352-7. doi: 10.1183/09031936.06.00139005. Epub 2006 Apr 12.
5
Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016.2012-2016 年新加坡非结核分枝杆菌病的临床和微生物学特征,重点是肺部疾病。
BMC Infect Dis. 2019 May 17;19(1):436. doi: 10.1186/s12879-019-3909-3.
6
Frequency and clinical significance of respiratory isolates of non-tuberculous mycobacteria in Riyadh, Saudi Arabia.沙特阿拉伯利雅得非结核分枝杆菌呼吸道分离株的频率及临床意义
Clin Respir J. 2016 Mar;10(2):198-203. doi: 10.1111/crj.12202. Epub 2014 Sep 4.
7
[The clinical analysis of chronic obstructive pulmonary disease patients complicated with nontuberculous mycobacterial pulmonary disease].[慢性阻塞性肺疾病合并非结核分枝杆菌肺病患者的临床分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2019 Nov 12;42(11):826-831. doi: 10.3760/cma.j.issn.1001-0939.2019.11.008.
8
Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease.非结核分枝杆菌感染后的慢性肺曲霉病:一种新兴疾病。
J Fungi (Basel). 2020 Dec 8;6(4):346. doi: 10.3390/jof6040346.
9
Radiologic Characteristics of Non-tuberculous Mycobacteria Infection in Patients with Bronchiectasis.支气管扩张症患者中非结核分枝杆菌感染的放射学特征。
Lung. 2020 Aug;198(4):715-722. doi: 10.1007/s00408-020-00371-0. Epub 2020 Jun 26.
10
[Clinical analysis of non-tuberculous mycobacterial pulmonary diseases in patients with mechanical ventilation].[机械通气患者非结核分枝杆菌肺病的临床分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Aug;31(8):1033-1036. doi: 10.3760/cma.j.issn.2095-4352.2019.08.024.

引用本文的文献

1
Negligible clinical impact of subsequent non-tuberculous mycobacteria isolation during MDR/RR-TB treatment: a 9-year retrospective cohort study from Wenzhou, China.耐多药/利福平耐药结核病治疗期间后续非结核分枝杆菌分离的临床影响可忽略不计:来自中国温州的一项9年回顾性队列研究
BMC Infect Dis. 2025 Jul 24;25(1):942. doi: 10.1186/s12879-025-11336-0.
2
The Advance and Clinical Practice on Lung Disease Caused by .由……引起的肺部疾病的进展与临床实践 (你提供的原文不完整,这里只是根据现有内容翻译)
Infect Drug Resist. 2025 Jun 25;18:3103-3115. doi: 10.2147/IDR.S524214. eCollection 2025.
3
Risk Factors and Long-Term Prognosis for Coinfection of Nontuberculous Mycobacterial Pulmonary Disease and Chronic Pulmonary Aspergillosis: A Multicentre Observational Study in Japan.

本文引用的文献

1
Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease.非结核分枝杆菌感染后的慢性肺曲霉病:一种新兴疾病。
J Fungi (Basel). 2020 Dec 8;6(4):346. doi: 10.3390/jof6040346.
2
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.非结核分枝杆菌肺病的治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学与感染病学会/美国感染病学会官方临床实践指南
Eur Respir J. 2020 Jul 7;56(1). doi: 10.1183/13993003.00535-2020. Print 2020 Jul.
3
Concomitant Presence of Species and Species in the Respiratory Tract of Patients: Underestimated Co-occurrence?
非结核分枝杆菌肺病与慢性肺曲霉病合并感染的危险因素及长期预后:日本一项多中心观察性研究
Mycoses. 2025 Jun;68(6):e70083. doi: 10.1111/myc.70083.
4
Lung Microenvironment Among Patients with Nontuberculous Mycobacterial Pulmonary Disease by Metagenomic Sequencing Technique.采用宏基因组测序技术分析非结核分枝杆菌肺病患者的肺微环境
Biomedicines. 2025 Mar 28;13(4):818. doi: 10.3390/biomedicines13040818.
5
Identification of prognostic factors of chronic pulmonary aspergillosis: a retrospective cohort of 106 patients.慢性肺曲霉病预后因素的识别:一项针对106例患者的回顾性队列研究。
J Thorac Dis. 2024 Nov 30;16(11):7310-7319. doi: 10.21037/jtd-24-831. Epub 2024 Nov 14.
6
The Association of Chronic Pulmonary Aspergillosis and Chronic Pulmonary Histoplasmosis with MDR-TB Patients in Indonesia.印度尼西亚慢性肺曲霉病和慢性肺组织胞浆菌病与耐多药结核病患者的关联
J Fungi (Basel). 2024 Jul 29;10(8):529. doi: 10.3390/jof10080529.
7
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.囊性纤维化患者中非结核分枝杆菌肺病的临床管理中可治疗的特征和挑战。
Respir Res. 2023 Dec 16;24(1):316. doi: 10.1186/s12931-023-02612-1.
8
Lady Windermere syndrome with haemoptysis: suspected pulmonary aspergilloma and MAC pulmonary disease.肺曲霉菌病和 MAC 肺病:伴有咯血的肺静脉闭塞症/肺朗格汉斯组织细胞增生症。
BMJ Case Rep. 2023 Sep 15;16(9):e256349. doi: 10.1136/bcr-2023-256349.
患者呼吸道中 物种与 物种的共存:共现情况是否被低估?
Front Microbiol. 2020 Jan 10;10:2980. doi: 10.3389/fmicb.2019.02980. eCollection 2019.
4
Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease.鸟分枝杆菌复合群肺病患者发生慢性肺曲霉病的风险分层
J Infect Chemother. 2018 Aug;24(8):654-659. doi: 10.1016/j.jiac.2018.04.002. Epub 2018 Apr 26.
5
Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病患者发生慢性肺曲霉病的危险因素。
PLoS One. 2017 Nov 30;12(11):e0188716. doi: 10.1371/journal.pone.0188716. eCollection 2017.
6
The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.非结核分枝杆菌患者发生慢性肺曲霉病的危险因素以及合并非结核分枝杆菌感染的慢性肺曲霉病患者的临床特征和转归。
Med Mycol. 2016 Feb;54(2):120-7. doi: 10.1093/mmy/myv093. Epub 2015 Nov 3.
7
Nontuberculous mycobacteria infections in immunosuppressed hosts.免疫抑制宿主中的非结核分枝杆菌感染
Clin Chest Med. 2015 Mar;36(1):91-9. doi: 10.1016/j.ccm.2014.11.002. Epub 2014 Dec 23.
8
Chronic pulmonary aspergillosis: an update on diagnosis and treatment.慢性肺曲霉病:诊断与治疗的最新进展
Respiration. 2014;88(2):162-74. doi: 10.1159/000362674. Epub 2014 Jun 17.
9
Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症中的鸟分枝杆菌复合群感染
Respirology. 2014 Jul;19(5):714-22. doi: 10.1111/resp.12287. Epub 2014 Apr 1.
10
Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada.在加拿大安大略省的肺结核患者中分离非结核分枝杆菌。
Int J Tuberc Lung Dis. 2013 May;17(5):676-81. doi: 10.5588/ijtld.12.0684.